(Q39565632)

13 September 2017

title

Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia (English)

1 reference

13 September 2017

0 references

Dean NC

1

1 reference

13 September 2017

Silver MP

2

1 reference

13 September 2017

Bateman KA

3

1 reference

13 September 2017

James B

4

1 reference

13 September 2017

Hadlock CJ

5

1 reference

13 September 2017

Hale D

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

American Journal of Medicine

13 September 2017

published in

1 reference

13 September 2017

volume

110

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

451-457

1 reference

The cost of treating community-acquired pneumonia.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Antimicrobial treatment of community acquired pneumonia in adults: A conference report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Evidence for the effectiveness of CME. A review of 50 randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Cesarean section rates in the United States. The short-term failure of the National Consensus Development Conference in 1980.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Changing physicians' practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Implementing clinical practice guidelines: social influence strategies and practitioner behavior change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Internists' attitudes about clinical practice guidelines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Implementation of admission decision support for community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Frequency of subspecialty physician care for elderly patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Quality of care, process, and outcomes in elderly patients with pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Heparin prophylaxis for medical patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Community-acquired pneumonia: can it be defined with claims data?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2800%2900744-0

10.1016/S0002-9343(00)00744-0

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference